Slingshot Insights | Tara Overview

TARA Overview

Upcoming Projects (TARA)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (TARA)

Looking at Updated NMIBC data from Protara's TARA-002 and Relmanda Therapeutics NDV-01
Tickers: TARA, RLMD
Executed On: Dec 23, 2025 at 10:00 AM EST
Discussing new data on AstraZeneca’s Imfinzi (durvalumab) in NMIBC and Roche’s Tecentriq (atezolizumab) in MIBC Presented at ESMO 2025
Tickers: AZN, RHHBY, NTRA, PFE, IBRX, CGON, MRK, JNJ, URGN, AURA, TARA, BMY
Executed On: Dec 08, 2025 at 06:00 PM EST
A Fourth Look: Discussing intermediate-risk (IR) and high-risk (HR) non-muscle invasive bladder cancer (NMIBC)
Tickers: TARA, CGON, JNJ, URGN, ENGN
Executed On: Jun 18, 2025 at 05:00 PM EDT
A Third Look: Discussing intermediate-risk (IR) and high-risk (HR) non-muscle invasive bladder cancer (NMIBC)
Tickers: TARA, CGON, JNJ, URGN, ENGN
Executed On: Jun 11, 2025 at 05:30 PM EDT
Discussing therapies for Choline Deficiency on Parenteral Support including the results from the THRIVE-1 clinical trial
Ticker: TARA
Executed On: Mar 26, 2025 at 11:00 AM EDT
A Second Look: Discussing intermediate-risk (IR) and high-risk (HR) non-muscle invasive bladder cancer (NMIBC)
Tickers: TARA, CGON, JNJ, URGN, ENGN
Executed On: Mar 11, 2025 at 06:00 PM EDT
A Second Look: Discussing intermediate-risk (IR) and high-risk (HR) non-muscle invasive bladder cancer (NMIBC) with a community physician
Tickers: TARA, ENGN, CGON, JNJ, URGN
Executed On: Feb 20, 2025 at 04:15 PM EST
Discussing intermediate-risk (IR) and high-risk (HR) non-muscle invasive bladder cancer (NMIBC)
Tickers: TARA, ENGN, CGON, JNJ, URGN
Executed On: Feb 05, 2025 at 01:30 PM EST

Upcoming & Overdue Catalysts (TARA)

Don’t see a catalyst related to the company you care about? Create your own!

Strategic Initiatives (TARA)

Don’t see a strategic initiative related to the company you care about? Create your own!